{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:29:21Z","timestamp":1786487361017,"version":"build-2736575974"},"reference-count":146,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["DIP-2024-021"],"award-info":[{"award-number":["DIP-2024-021"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpha.2025.101538","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:26:07Z","timestamp":1767889567000},"page":"101538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways"],"prefix":"10.1016","volume":"16","author":[{"given":"Chenyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murni Nazira","family":"Sarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-8606","authenticated-orcid":false,"given":"Theebaa","family":"Anasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-5000","authenticated-orcid":false,"given":"Hamizah Shahirah","family":"Hamezah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101538_bib1","first-page":"477","article-title":"Breast cancer statistics 2024, CA Cancer","volume":"74","author":"Giaquinto","year":"2024","journal-title":"J. Clin."},{"key":"10.1016\/j.jpha.2025.101538_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1385272827666230423144150","article-title":"Anthracycline in medicinal chemistry: mechanism of cardiotoxicity, preventive and treatment strategies","volume":"27","author":"Hussen","year":"2023","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/biom13010093","article-title":"PI3K-AKT-targeting breast cancer treatments: natural products and synthetic compounds","volume":"13","author":"Yuan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpha.2025.101538_bib4","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.e23276","article-title":"Cancer statistics: the United States vs. worldwide","volume":"42","author":"Desai","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"2024","key":"10.1016\/j.jpha.2025.101538_bib5","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jpha.2025.101538_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.ctdb.2023.02.009","article-title":"Polarity in breast development and cancer","volume":"154","author":"Whitford","year":"2023","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.jpha.2025.101538_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.02.006","article-title":"Breast cancer models: engineering the tumor microenvironment","volume":"106","author":"Bahcecioglu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jpha.2025.101538_bib8","article-title":"Facing the CDK4\/6i resistance dilemma in patients with breast cancer, exploration of the resistance mechanism and possible reverse strategy: a narrative review","volume":"101","author":"Wu","year":"2022","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jpha.2025.101538_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2025.101538_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jpha.2025.101538_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-023-07137-1","article-title":"Hereditary cancer testing in a diverse sample across three breast imaging centers","volume":"203","author":"Westbrook","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpha.2025.101538_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgq069","article-title":"BRCA1 and BRCA2 breast\/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair","volume":"31","author":"O'Donovan","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101538_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1284552","article-title":"Supplementation of dietary semen vaccariae extracts to lactating sow diets: effects on the production performance, milk components, and gene expression related to mammogenesis","volume":"10","author":"Xu","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.jpha.2025.101538_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2020.12.004","article-title":"The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives","volume":"82","author":"Sukocheva","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2025.101538_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113034","article-title":"Mammary hydroxylated oestrogen activates the NLRP3 inflammasome in tumor-associated macrophages to promote breast cancer progression and metastasis","volume":"142","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpha.2025.101538_bib16","article-title":"Tumor dormancy in bone","volume":"3","author":"Mayhew","year":"2020","journal-title":"Cancer Rep"},{"key":"10.1016\/j.jpha.2025.101538_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jpha.2025.101538_bib18","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-22-0090","article-title":"Single-cell transcriptome profiling reveals intratumoral heterogeneity and molecular features of ductal carcinoma in situ","volume":"82","author":"Tokura","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113632","article-title":"Recent advances of quinones as a privileged structure in drug discovery","volume":"223","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib20","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.21873\/anticanres.15151","article-title":"Pretreatment absolute lymphocyte count and neutrophil-to-lymphocyte ratio are prognostic factors for stage III breast cancer","volume":"41","author":"Yamanouchi","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib21","first-page":"1239","article-title":"Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases","volume":"39","author":"Kusama","year":"2012","journal-title":"Gan. To. Kagaku. Ryoho."},{"key":"10.1016\/j.jpha.2025.101538_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-020-05591-9","article-title":"Outcomes of primary endocrine therapy in elderly women with stage I\u2013III breast cancer: a SEER database analysis","volume":"180","author":"Yuan","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpha.2025.101538_bib23","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"10.1016\/j.jpha.2025.101538_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.19.01525","article-title":"Systematic review of the cost effectiveness of breast cancer prevention, screening, and treatment interventions","volume":"38","author":"Jayasekera","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11912-023-01393-6","article-title":"Advances in endocrine therapy for hormone receptor-positive advanced breast cancer","volume":"25","author":"Ziyeh","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101538_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/cancers16040800","article-title":"Next-generation HER2-targeted antibody\u2013drug conjugates in breast cancer","volume":"16","author":"Zimmerman","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101538_bib27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00280-016-3027-5","article-title":"Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer","volume":"77","author":"Farhat","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101538_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jpha.2025.101538_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib30","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.3390\/cancers14174332","article-title":"PARP inhibitors for breast cancer: Germline BRCA1\/2 and beyond","volume":"14","author":"Menezes","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101538_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jpha.2025.101538_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1491099","article-title":"Progress on angiogenic and antiangiogenic agents in the tumor microenvironment","volume":"14","author":"Xu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.jpha.2025.101538_bib34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/genes12071094","article-title":"The importance of being PI3K in the RAS signaling network","volume":"12","author":"Cuesta","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jpha.2025.101538_bib35","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.2174\/1381612827666210118122909","article-title":"AKT\/GSK-3 pathway targeting; botanicals and bioactive compounds with anticancer activities","volume":"27","author":"Jalali","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2025.101538_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000488087","article-title":"Anti-angiogenics: current situation and future perspectives","volume":"41","author":"Zirlik","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.jpha.2025.101538_bib37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/bph.16275","article-title":"Potential of natural flavonoids to target breast cancer angiogenesis","volume":"182","author":"Wang","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101538_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154513","article-title":"Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1\u03b1 in tumors and DLL4 activity in the endothelium","volume":"108","author":"Cha","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpha.2025.101538_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101626","article-title":"Progress in understanding of the stalk and tip cells formation involvement in angiogenesis mechanisms","volume":"73","author":"Zeng","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jpha.2025.101538_bib40","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1158\/1078-0432.CCR-20-3017","article-title":"Combining neratinib with CDK4\/6, mTOR, and MEK inhibitors in models of HER2-positive cancer","volume":"27","author":"Zhao","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib41","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101538_bib42","doi-asserted-by":"crossref","first-page":"49349","DOI":"10.18632\/oncotarget.9885","article-title":"Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment","volume":"7","author":"Fang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101538_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","article-title":"The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis","volume":"20","author":"Yoshimura","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2025.101538_bib44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-018-4760-8","article-title":"MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis","volume":"170","author":"Dutta","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpha.2025.101538_bib45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/cmi.2015.106","article-title":"MCP-1-induced ERK\/GSK-3\u03b2\/Snail signaling facilitates the epithelial\u2013mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells","volume":"14","author":"Li","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2025.101538_bib46","article-title":"Pharmacokinetics of anthraquinones from medicinal plants","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101538_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jare.2021.11.007","article-title":"Diverse host-associated fungal systems as a dynamic source of novel bioactive anthraquinones in drug discovery: current status and future perspectives","volume":"39","author":"Shakour","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jpha.2025.101538_bib48","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1002\/anie.200806121","article-title":"The biosynthetic logic of polyketide diversity","volume":"48","author":"Hertweck","year":"2009","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jpha.2025.101538_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/0118722083301761240628083511","article-title":"Unveiling anthraquinones: diverse health benefits of an essential secondary metabolite","volume":"19","author":"Khatoon","year":"2025","journal-title":"Recent Pat. Biotechnol."},{"key":"10.1016\/j.jpha.2025.101538_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.132957","article-title":"Reductive elimination of alkoxy group in anthraquinone derivatives","volume":"122","author":"Tikhomirov","year":"2022","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jpha.2025.101538_bib51","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1021\/acs.chemrev.5b00400","article-title":"Use of bromine and bromo-organic compounds in organic synthesis","volume":"116","author":"Saikia","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jpha.2025.101538_bib52","series-title":"Synthesis and Properties of Anthraquinones Labeled Nucleobases","author":"Phillips","year":"2010"},{"key":"10.1016\/j.jpha.2025.101538_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134422","article-title":"Natural edible pigments: a comprehensive review of resource, chemical classification, biosynthesis pathway, separated methods and application","volume":"403","author":"Shen","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib54","article-title":"A novel navigated doxorubicin delivery formulation to breast cancer therapy","volume":"14","author":"Cheng","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.jpha.2025.101538_bib55","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1021\/acs.chemrev.6b00621","article-title":"Heteroatom\u2013heteroatom bond formation in natural product biosynthesis","volume":"117","author":"Waldman","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jpha.2025.101538_bib56","doi-asserted-by":"crossref","first-page":"35806","DOI":"10.1039\/D1RA05686G","article-title":"Journey of anthraquinones as anticancer agents\u2013a systematic review of recent literature","volume":"11","author":"Malik","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpha.2025.101538_bib57","first-page":"271","article-title":"Synthesis of new anthraquinone derivatives and anticancer effects on breast cancer cell lines","volume":"4","author":"Haciosmanoglu","year":"2018","journal-title":"Eurasia. Proc. Sci. Technol. Eng. Math."},{"key":"10.1016\/j.jpha.2025.101538_bib58","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765202520241466","article-title":"In vitro antitumor activity and electrochemical studies of bio-electroactive anthraquinone derivatives in glioblastoma","volume":"97","author":"Silva","year":"2025","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.jpha.2025.101538_bib59","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00044-020-02563-y","article-title":"Inducing apoptosis through upregulation of p53: Structure\u2013activity exploration of anthraquinone analogs","volume":"29","author":"Anifowose","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jpha.2025.101538_bib60","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1080\/10406638.2023.2209249","article-title":"Spectroscopic characterization, quantum chemical and molecular docking studies on 1-chloroanthraquinone: a novel oral squamous cell carcinoma drug","volume":"44","author":"Valarmathi","year":"2024","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.jpha.2025.101538_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126786","article-title":"Upregulation of p53 through induction of MDM2 degradation: amino acid prodrugs of anthraquinone analogs","volume":"30","author":"Anifowose","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jpha.2025.101538_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/1535-7163.MCT-17-0566","article-title":"Inhibition of MDM2 by a rhein-derived compound AQ-101 suppresses cancer development in SCID mice","volume":"17","author":"Gu","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.jpha.2025.101538_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/metabo13010023","article-title":"Chemodiversity and anti-leukemia effect of metabolites from Penicillium setosum CMLD 18","volume":"13","author":"de Carvalho","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jpha.2025.101538_bib64","doi-asserted-by":"crossref","first-page":"10367","DOI":"10.3390\/molecules180910367","article-title":"3-bromo-1-hydroxy-9, 10-anthraquinone (BHAQ) inhibits growth and migration of the human breast cancer cell lines MCF-7 and MDA-MB231","volume":"18","author":"Abu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2025.101538_bib65","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00044-012-0197-5","article-title":"Synthesis of damnacanthal, a naturally occurring 9, 10-anthraquinone and its analogues, and its biological evaluation against five cancer cell lines","volume":"22","author":"Saha","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jpha.2025.101538_bib66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phytochem.2017.02.003","article-title":"Photosensitizing anthraquinones from Heterophyllaea lycioides (Rubiaceae)","volume":"137","author":"Dimmer","year":"2017","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jpha.2025.101538_bib67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02980120","article-title":"5-Arylidene-2(5H)-furanone derivatives: synthesis and structure-activity relationship for cytotoxicity","volume":"27","author":"Bang","year":"2004","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.jpha.2025.101538_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.mencom.2018.05.009","article-title":"Electrochemical reduction, radical anions and solvation energies of 1, 2, 3, 4-tetrafluoro-9, 10-anthraquinone and its N-piperidyl derivatives in DMF and DMF\u2013water mixtures","volume":"28","author":"Shundrin","year":"2018","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.jpha.2025.101538_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/cssc.202401057","article-title":"Protodefluorinated selectfluor\u00ae aggregatively activates selectfluor\u00ae for efficient radical C(sp3)\u2013H fluorination reactions","volume":"17","author":"Yakubov","year":"2024","journal-title":"ChemSusChem"},{"key":"10.1016\/j.jpha.2025.101538_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117380","article-title":"Highlights on U.S. FDA-approved halogen-containing drugs in 2024","volume":"287","author":"Ali","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111082","article-title":"The influence of the chlorine atom on the biological activity of 2\u2032-hydroxychalcone in relation to the lipid phase of biological membranes-anticancer and antimicrobial activity","volume":"398","author":"Cyboran-Miko\u0142ajczyk","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2025.101538_bib72","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/ph16081162","article-title":"Chemistry and pharmacology of fluorinated drugs approved by the FDA (2016\u20132022)","volume":"16","author":"Shabir","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpha.2025.101538_bib73","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.bbamem.2016.06.025","article-title":"Biophysics in cancer: the relevance of drug-membrane interaction studies","volume":"1858","author":"Alves","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpha.2025.101538_bib74","article-title":"I-124 labeled anthraquinone-derivative-coating gold nanoparticles for targeted breast cancer diagnosis and therapy","author":"Lee","year":"2024","journal-title":"Preprints"},{"key":"10.1016\/j.jpha.2025.101538_bib75","article-title":"Comparative density functional theory study on the relative gas phase enthalpies and free energies of formation for the mono-through hepta-halogenated (X= F, Cl, Br) anthraquinones","author":"Rayne","year":"2010","journal-title":"Nat. Prec."},{"key":"10.1016\/j.jpha.2025.101538_bib76","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.electacta.2016.12.065","article-title":"Understanding the mechanism of improvement in practical specific capacity using halogen substituted anthraquinones as cathode materials in lithium batteries","volume":"224","author":"Zhang","year":"2017","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.jpha.2025.101538_bib77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/cryst14040325","article-title":"Preference in the type of halogen bonding interactions within co-crystals of anthraquinone with a pair of isosteric perhalobenzenes","volume":"14","author":"Bosch","year":"2024","journal-title":"Crystals"},{"key":"10.1016\/j.jpha.2025.101538_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146738","article-title":"Manipulating fluorine induced bulky dipoles and their strong interaction to achieve high efficiency electric energy storage performance in polymer dielectrics","volume":"476","author":"Cheng","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jpha.2025.101538_bib79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ieam.4352","article-title":"A critical review of a recommended analytical and classification approach for organic fluorinated compounds with an emphasis on per- and polyfluoroalkyl substances","volume":"17","author":"Fiedler","year":"2021","journal-title":"Integrated Environ. Assess. Manag."},{"key":"10.1016\/j.jpha.2025.101538_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108407","article-title":"The alternation of halobenzoquinone disinfection byproduct on toxicogenomics of DNA damage and repair in uroepithelial cells","volume":"183","author":"Zhang","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.jpha.2025.101538_bib81","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1021\/acs.est.7b06428","article-title":"Halobenzoquinone-induced alteration of gene expression associated with oxidative stress signaling pathways","volume":"52","author":"Li","year":"2018","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jpha.2025.101538_bib82","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1021\/acs.est.5b05585","article-title":"Emerging disinfection byproducts, halobenzoquinones: effects of isomeric structure and halogen substitution on cytotoxicity, formation of reactive oxygen species, and genotoxicity","volume":"50","author":"Li","year":"2016","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jpha.2025.101538_bib83","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.3390\/molecules26226825","article-title":"Antiviral activities of halogenated emodin derivatives against human coronavirus NL63","volume":"26","author":"Horvat","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2025.101538_bib84","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1021\/jm0608154","article-title":"Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides","volume":"49","author":"Pors","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib85","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1080\/07391102.2021.1951354","article-title":"Unveiling the mechanistic roles of chlorine substituted phthalazinone-based compounds containing chlorophenyl moiety towards the differential inhibition of poly (ADP-ribose) polymerase-1 in the treatment of lung cancer","volume":"40","author":"Okunlola","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jpha.2025.101538_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acsmedchemlett.9b00509","article-title":"Vorasidenib (AG-881): a first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma","volume":"11","author":"Konteatis","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jpha.2025.101538_bib87","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.2174\/1381612824666181106101448","article-title":"Computational and experimental binding mechanism of DNA-drug interactions","volume":"24","author":"Selvaraj","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2025.101538_bib88","doi-asserted-by":"crossref","first-page":"16589","DOI":"10.1021\/acs.jmedchem.2c01422","article-title":"Discovery of GDC-0077 (inavolisib), a highly selective inhibitor and degrader of mutant PI3K\u03b1","volume":"65","author":"Hanan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib89","article-title":"Structural insights into the development of inhibitors against cancer-specific mutations of PI3K\u03b1","volume":"120","author":"Liu","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpha.2025.101538_bib90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/antiox8040082","article-title":"Protective effect of glutathione against oxidative stress-induced cytotoxicity in RAW 264.7 macrophages through activating the nuclear factor erythroid 2-related factor-2\/heme oxygenase-1 pathway","volume":"8","author":"Kwon","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.jpha.2025.101538_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/576384","article-title":"Angiogenesis and breast cancer","volume":"2010","author":"Longatto Filho","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib92","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.8095","article-title":"Effect of emodin on expression of VEGF-A and VEGFR_2 genes in human breast carcinoma MCF-7 cell","volume":"10","author":"Cheshmi","year":"2017","journal-title":"Int. J. Cancer Manag"},{"key":"10.1016\/j.jpha.2025.101538_bib93","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s11418-021-01526-w","article-title":"Inhibition of cell-intrinsic NF-\u03baB activity and metastatic abilities of breast cancer by Aloe-emodin and emodic-acid isolated from Asphodelus microcarpus","volume":"75","author":"Abdellatef","year":"2021","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.jpha.2025.101538_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cbi.2011.03.013","article-title":"Rhein inhibits angiogenesis and the viability of hormone-dependent and-independent cancer cells under normoxic or hypoxic conditions in vitro","volume":"192","author":"Fernand","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2025.101538_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115972","article-title":"1, 8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1\u03b1 downregulation","volume":"220","author":"Hwang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101538_bib96","first-page":"1295","article-title":"Notch1 is involved in migration and invasion of human breast cancer cells","volume":"26","author":"Wang","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101538_bib97","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12885-015-1625-y","article-title":"Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpha.2025.101538_bib98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/or.2021.8026","article-title":"Research and application of hydrostatic high pressure in tumor vaccines","volume":"45","author":"Yan","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101538_bib99","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.3390\/ijms25168651","article-title":"Antibody drug conjugates for cancer therapy: from metallodrugs to nature-inspired payloads","volume":"25","author":"Tonon","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101538_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.01.029","article-title":"Chemotherapeutic drug delivery by tumoral extracellular matrix targeting","volume":"274","author":"Raav\u00e9","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jpha.2025.101538_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(22)02420-5","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial","volume":"401","author":"Hurvitz","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2025.101538_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100497","article-title":"The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer","volume":"7","author":"Michaleas","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.jpha.2025.101538_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jpha.2025.101538_bib104","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","article-title":"Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial","volume":"19","author":"Loibl","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1158\/1078-0432.CCR-23-3571","article-title":"From serendipity to intention: development of brain-penetrant PARP1-selective inhibitors","volume":"30","author":"Lynce","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib106","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4161\/cc.3.8.1023","article-title":"Analysis of FDA approved anticancer drugs reveals the future of cancer therapy","volume":"3","author":"Blagosklonny","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jpha.2025.101538_bib107","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.2174\/1568026618666180118153502","article-title":"ADME and safety aspects of non-cleavable linkers in drug discovery and development","volume":"17","author":"Walles","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101538_bib108","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2147\/OTT.S100499","article-title":"Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer","volume":"9","author":"Ma","year":"2016","journal-title":"Onco. Targets Ther"},{"key":"10.1016\/j.jpha.2025.101538_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107778","article-title":"Peripheral neuropathy associated with monomethyl auristatin E-based antibody-drug conjugates","volume":"26","author":"Fu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jpha.2025.101538_bib110","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1535-7163.MCT-16-0408","article-title":"Mechanisms of resistance to antibody-drug conjugates","volume":"15","author":"Loganzo","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.jpha.2025.101538_bib111","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2012.10.027","article-title":"Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression","volume":"48","author":"Choi","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jpha.2025.101538_bib112","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jcpt.13349","article-title":"Haematologic toxicities with PARP inhibitors in cancer patients: an up-to-date meta-analysis of 29 randomized controlled trials","volume":"46","author":"Wang","year":"2021","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.jpha.2025.101538_bib113","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/jcm13051218","article-title":"Cardioprotective effects of PARP inhibitors: a re-analysis of a meta-analysis and a real-word data analysis using the FAERS database","volume":"13","author":"Han","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpha.2025.101538_bib114","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.annonc.2024.01.003","article-title":"Longitudinal profiling identifies co-occurring BRCA1\/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer","volume":"35","author":"Harvey-Jones","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib115","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022113190","article-title":"Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity","volume":"42","author":"Serrano-Benitez","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.jpha.2025.101538_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202307865","article-title":"Anti-HER2 immunoliposomes: antitumor efficacy attributable to targeted delivery of anthraquinone-fused enediyne","volume":"11","author":"Feng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jpha.2025.101538_bib117","series-title":"Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment","author":"Uustare","year":"2020"},{"key":"10.1016\/j.jpha.2025.101538_bib118","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae331","article-title":"2\u2032-Fluorinated nucleoside chemistry for new drug discovery: achievements and prospects","volume":"11","author":"Meng","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.jpha.2025.101538_bib119","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.bbadis.2018.01.002","article-title":"Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects","volume":"1864","author":"Guha","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jpha.2025.101538_bib120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101538_bib121","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","article-title":"Nerve-to-cancer transfer of mitochondria during cancer metastasis","volume":"644","author":"Hoover","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101538_bib122","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12672-025-02240-9","article-title":"Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective","volume":"16","author":"Thakral","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jpha.2025.101538_bib123","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/molecules25071672","article-title":"Novel anthraquinone compounds inhibit colon cancer cell proliferation via the reactive oxygen species\/JNK pathway","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2025.101538_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"Formation and biological targets of quinones: cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpha.2025.101538_bib125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpha.2025.101538_bib126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41588-022-01258-x","article-title":"Dynamics of DNA hydroxymethylation and methylation during mouse embryonic and germline development","volume":"55","author":"Yan","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jpha.2025.101538_bib127","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2025.101538_bib128","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.cr.7290321","article-title":"Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells","volume":"15","author":"Wang","year":"2005","journal-title":"Cell. Res"},{"key":"10.1016\/j.jpha.2025.101538_bib129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1159\/000477886","article-title":"Induction of apoptosis in HepaRG cell line by Aloe-emodin through generation of reactive oxygen species and the mitochondrial pathway","volume":"42","author":"Dong","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jpha.2025.101538_bib130","first-page":"309","article-title":"The roles of endoplasmic reticulum stress and Ca2+ on rhein-induced apoptosis in A-549 human lung cancer cells","volume":"29","author":"Hsia","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110089","article-title":"Emodin-induced hepatotoxicity is enhanced by 3-methylcholanthrene through activating aryl hydrocarbon receptor and inducing CYP1A1 in vitro and in vivo","volume":"365","author":"Wang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2025.101538_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9474823","article-title":"Mechanisms of anthracycline-enhanced reactive oxygen metabolism in tumor cells","volume":"2019","author":"Doroshow","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2025.101538_bib133","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.3390\/ijms26146617","article-title":"PCSK9 inhibitor inclisiran attenuates cardiotoxicity induced by sequential anthracycline and trastuzumab exposure via NLRP3 and MyD88 pathway inhibition","volume":"26","author":"Quagliariello","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101538_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152328","article-title":"Sex-based differences in mitochondrial activity and cellular calcium signaling in isolated mice cardiomyocytes intervened by doxorubicin","volume":"778","author":"He","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2025.101538_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191610413","article-title":"Acute and subchronic oral toxicity of anthraquinone in sprague dawley rats","volume":"19","author":"Qu","year":"2022","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.jpha.2025.101538_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111313","article-title":"Liver toxicity of anthraquinones: a combined in vitro cytotoxicity and in silico reverse dosimetry evaluation","volume":"140","author":"Liu","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jpha.2025.101538_bib137","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12906-018-2253-2","article-title":"Cytotoxic properties of the anthraquinone derivatives isolated from the roots of Rubia philippinensis","volume":"18","author":"Bajpai","year":"2018","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.jpha.2025.101538_bib138","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/med.21391","article-title":"Anthraquinones as pharmacological tools and drugs","volume":"36","author":"Malik","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jpha.2025.101538_bib139","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P","article-title":"Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial","volume":"43","author":"Pelletier","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpha.2025.101538_bib140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxlet.2023.10.002","article-title":"Genetic and prenatal developmental evaluation of anthraquinone","volume":"388","author":"Qu","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpha.2025.101538_bib141","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2174\/138161209788682514","article-title":"Comprehensive assessment of ADMET risks in drug discovery","volume":"15","author":"Wang","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2025.101538_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115122","article-title":"Comprehensive investigation on the metabolism of emodin both in vivo and in vitro","volume":"223","author":"Zhou","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpha.2025.101538_bib143","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/10837450.2025.2489743","article-title":"Nanoparticles co-loaded with sorafenib and emodin: preparation and efficacy against liver cancancer incerin vitroandin vivo","volume":"30","author":"Jiang","year":"2025","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.jpha.2025.101538_bib144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-024-02981-5","article-title":"Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101538_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113031","article-title":"Mitochondrial ROS inhibition prevents doxorubicin-induced breast cancer cell migration and invasion","volume":"28","author":"Capeloa","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jpha.2025.101538_bib146","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/187231211798472575","article-title":"Systematic and pairwise analysis of the effects of aromatic halogenation and trifluoromethyl substitution on human liver microsomal clearance","volume":"5","author":"Sun","year":"2011","journal-title":"Drug Metabol. Lett."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:54:03Z","timestamp":1786485243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2095177925003557"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101538","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101538"}}